chronic obstructive pulmonary disease and asthma devices market size, chronic obstructive pulmonary disease market, copd and asthma devices industry, copd and asthma devices market analysis, chronic obstructive pulmonary disease and asthma devices market analysis, copd and asthma devices market growth
What are the latest figures on the chronic obstructive pulmonary disease (copd) and asthma devices market’s size and projected CAGR?
The chronic obstructive pulmonary disease (COPD) and asthma devices market size has grown strongly in recent years. It will grow from $44.95 billion in 2024 to $47.83 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to growth in the elderly population, increasing incidence of allergies, increasing government initiatives, rise in clinical research and trials, and rise in urbanization.
The chronic obstructive pulmonary disease (COPD) and asthma devices market size is expected to see strong growth in the next few years. It will grow to $60.53 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to rising occurrences of respiratory diseases, rising smoking of cigarettes, rising environmental pollution levels and breathing problems, growing prevalence of respiratory diseases, growing healthcare expenditure, and rising portability of drug delivery devices. Major trends in the forecast period include technological advancements, integration of smart technology, personalized medicine, adoption of biologics, and wearable respiratory monitors.
Get Your Free Sample of The Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18298&type=smp
Which Market drivers have played a significant role in driving the chronic obstructive pulmonary disease (copd) and asthma devices market?
The growing prevalence of respiratory diseases is expected to propel the growth of the chronic obstructive pulmonary disease (COPD) and asthma devices market going forward. Respiratory diseases encompass many conditions affecting the lungs and respiratory systems, such as asthma, chronic obstructive pulmonary disease, pneumonia, and lung cancer, impacting breathing and overall respiratory function. The growing prevalence of respiratory diseases is due to increasing air pollution levels, changing climate patterns affecting allergens and pathogens, and lifestyle habits such as smoking that compromise respiratory health. COPD and asthma devices play a crucial role in the comprehensive management and treatment of respiratory diseases, supporting patients to achieve better respiratory health and enhance their overall well-being. For instance, in March 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, chronic obstructive pulmonary disease (COPD) ranked as the third leading cause of death globally, resulting in approximately 3.23 million fatalities. Further, nearly 90% of these deaths in individuals under 70 years old occurred in low- and middle-income countries (LMICs). Therefore, the growing prevalence of respiratory diseases drives the growth of the chronic obstructive pulmonary disease (COPD) and asthma devices markets.
What are the key segments within the chronic obstructive pulmonary disease (copd) and asthma devices market?
The chronic obstructive pulmonary disease (COPD) and asthma devices market covered in this report is segmented –
1) By Type: Metered Dose Inhalers, Drug Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Other Types
2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease
3) By Application: Hospitals, Clinics, Home Care Settings, Research Institutions, Other Applications
4) By End User: Pediatric, Adult, Geriatric
Subsegments:
1) By Metered Dose Inhalers: Conventional MDI, Breath-Actuated MDI
2) By Drug Powder Inhalers: Dry Powder Inhalers (DPI), Multi-Dose DPI
3) By Soft Mist Inhalers: Respimat Soft Mist Inhalers, Other Soft Mist Devices
4) By Jet Nebulizers: Pneumatic Nebulizers, Venturi-Type Nebulizers
5) By Ultrasonic Nebulizers: Tabletop Ultrasonic Nebulizers, Portable Ultrasonic Nebulizers
6) By Other Types: Nebulizer Accessories, Spacer Devices
Order your report now for swift delivery
Which key players are shaping the chronic obstructive pulmonary disease (copd) and asthma devices market?
Major companies operating in the chronic obstructive pulmonary disease (COPD) and asthma devices market are AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, 3M Health Care, Boehringer Ingelheim, Royal Philips NV, Teva Pharmaceuticals Industries Ltd., Baxter International Inc., Omron Corporation, Smiths Medical Inc., Recipharm AB, Cipla Ltd., Teleflex Incorporated, Chiesi Farmaceutici SpA, Lincre Holdings Inc., Sunovion Pharmaceuticals Inc., Verona Pharma plc, Drive DeVilbiss Healthcare, Pari Respiratory Equipment Inc., Allied Healthcare Products Inc., Clement Clarke International Ltd., Cohero Health Inc., Pneuma Respiratory Inc., Mundipharma International Ltd.
Which transformative trends will shape the chronic obstructive pulmonary disease (copd) and asthma devices market landscape?
Major companies operating in the chronic obstructive pulmonary disease (COPD) and asthma devices market are focusing on developing innovative technologies, such as inhalation devices, to integrate digital health features for remote monitoring and personalized treatment management. Inhalation devices are medical devices used to administer medications directly into the lungs through inhalation. For instance, in May 2022, Alkem Laboratories, an India-based pharmaceutical company, introduced the Innohaler, a dry powder inhaler (DPI) device, to make life easier for people with asthma and COPD. The Innohaler boasts advanced breath-actuated technology, ensuring precise medication delivery with each inhalation, optimizing dosage accuracy, and reducing waste. Its ergonomic design promotes ease of use, featuring a user-friendly interface that simplifies operation for patients of all ages. The device incorporates a compact and portable build, enhancing convenience for on-the-go use and improving patient adherence to prescribed treatments.
How do regional factors impact the chronic obstructive pulmonary disease (copd) and asthma devices market, and which region is the largest contributor?
North America was the largest region in the chronic obstructive pulmonary disease (COPD) and asthma devices market in 2023. The regions covered in the chronic obstructive pulmonary disease (COPD) and asthma devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Report 2025 Offer?
The chronic obstructive pulmonary disease (copd) and asthma devices market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Chronic obstructive pulmonary disease (COPD) and asthma devices refer to the medical devices used to manage and treat breathing and respiratory conditions. These devices help patients breathe more effectively, manage symptoms, and improve their quality of life.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18298
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
